Comparison Chart Gubra A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 05:48:38 2024-06-06 am EDT			5-day change	1st Jan Change
339.5 ^DKK	+4.14%		+3.65%	+172.80%

May. 07	Gubra A/S Announces Management Changes	CI
Apr. 17	Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	GUBRA A/S	Bio Therapeutic Drugs	+4.29%	+3.65%	+172.80%	+264.20%	-	774M